145 related articles for article (PubMed ID: 11154690)
1. Mechanistic inferences from the crystal structure of fumarylacetoacetate hydrolase with a bound phosphorus-based inhibitor.
Bateman RL; Bhanumoorthy P; Witte JF; McClard RW; Grompe M; Timm DE
J Biol Chem; 2001 May; 276(18):15284-91. PubMed ID: 11154690
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure and mechanism of a carbon-carbon bond hydrolase.
Timm DE; Mueller HA; Bhanumoorthy P; Harp JM; Bunick GJ
Structure; 1999 Sep; 7(9):1023-33. PubMed ID: 10508789
[TBL] [Abstract][Full Text] [Related]
3. Slow-onset inhibition of fumarylacetoacetate hydrolase by phosphinate mimics of the tetrahedral intermediate: kinetics, crystal structure and pharmacokinetics.
Bateman RL; Ashworth J; Witte JF; Baker LJ; Bhanumoorthy P; Timm DE; Hurley TD; Grompe M; McClard RW
Biochem J; 2007 Mar; 402(2):251-60. PubMed ID: 17064256
[TBL] [Abstract][Full Text] [Related]
4. Structural insight into substrate binding and catalysis of a novel 2-keto-3-deoxy-D-arabinonate dehydratase illustrates common mechanistic features of the FAH superfamily.
Brouns SJ; Barends TR; Worm P; Akerboom J; Turnbull AP; Salmon L; van der Oost J
J Mol Biol; 2008 May; 379(2):357-71. PubMed ID: 18448118
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Targeting of Fumaryl Acetoacetate Hydrolase in Hereditary Tyrosinemia Type I.
Gil-Martínez J; Macias I; Unione L; Bernardo-Seisdedos G; Lopitz-Otsoa F; Fernandez-Ramos D; Lain A; Sanz-Parra A; Mato JM; Millet O
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670179
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional analysis of a dimeric fumarylacetoacetate hydrolase (EaFAH) from psychrophilic Exiguobacterium antarcticum.
Yoo W; Lee CW; Kim BY; Huong Luu Le LT; Park SH; Kim HW; Shin SC; Kim KK; Lee JH; Kim TD
Biochem Biophys Res Commun; 2019 Feb; 509(3):773-778. PubMed ID: 30630595
[TBL] [Abstract][Full Text] [Related]
7. Cloning and expression of fumarylacetoacetate hydrolase derived from marine yeast Rhodosporidium diobovatum.
Liu Y; Xia W; Yang P; Zhang S; Shi Z; Tang H; Zhang L
J Basic Microbiol; 2015 Sep; 55(9):1082-93. PubMed ID: 25832819
[TBL] [Abstract][Full Text] [Related]
8. Hereditary tyrosinemia type I-associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate.
Macias I; Laín A; Bernardo-Seisdedos G; Gil D; Gonzalez E; Falcon-Perez JM; Millet O
J Biol Chem; 2019 Aug; 294(35):13051-13060. PubMed ID: 31300554
[TBL] [Abstract][Full Text] [Related]
9. Human γ-Glutamyl Transpeptidase 1: STRUCTURES OF THE FREE ENZYME, INHIBITOR-BOUND TETRAHEDRAL TRANSITION STATES, AND GLUTAMATE-BOUND ENZYME REVEAL NOVEL MOVEMENT WITHIN THE ACTIVE SITE DURING CATALYSIS.
Terzyan SS; Burgett AW; Heroux A; Smith CA; Mooers BH; Hanigan MH
J Biol Chem; 2015 Jul; 290(28):17576-86. PubMed ID: 26013825
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional analysis of missense mutations in fumarylacetoacetate hydrolase, the gene deficient in hereditary tyrosinemia type 1.
Bergeron A; D'Astous M; Timm DE; Tanguay RM
J Biol Chem; 2001 May; 276(18):15225-31. PubMed ID: 11278491
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of Cg1458 reveal a catalytic lid domain and a common catalytic mechanism for the FAH family.
Ran T; Gao Y; Marsh M; Zhu W; Wang M; Mao X; Xu L; Xu D; Wang W
Biochem J; 2013 Jan; 449(1):51-60. PubMed ID: 23046410
[TBL] [Abstract][Full Text] [Related]
12. X-ray structure of fumarylacetoacetate hydrolase family member Homo sapiens FLJ36880.
Manjasetty BA; Niesen FH; Delbrück H; Götz F; Sievert V; Büssow K; Behlke J; Heinemann U
Biol Chem; 2004 Oct; 385(10):935-42. PubMed ID: 15551868
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of Fumarylacetoacetate Hydrolase Domain Containing Protein 1 (FAHD1).
Weiss AKH; Wurzer R; Klapec P; Eder MP; Loeffler JR; von Grafenstein S; Monteleone S; Liedl KR; Jansen-Dürr P; Gstach H
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443596
[No Abstract] [Full Text] [Related]
14. The crystal structure of bacillus cereus phosphonoacetaldehyde hydrolase: insight into catalysis of phosphorus bond cleavage and catalytic diversification within the HAD enzyme superfamily.
Morais MC; Zhang W; Baker AS; Zhang G; Dunaway-Mariano D; Allen KN
Biochemistry; 2000 Aug; 39(34):10385-96. PubMed ID: 10956028
[TBL] [Abstract][Full Text] [Related]
15. The fumarylacetoacetate hydrolase (FAH) superfamily of enzymes: multifunctional enzymes from microbes to mitochondria.
Weiss AKH; Loeffler JR; Liedl KR; Gstach H; Jansen-Dürr P
Biochem Soc Trans; 2018 Apr; 46(2):295-309. PubMed ID: 29487229
[TBL] [Abstract][Full Text] [Related]
16. The bacterial
Kuatsjah E; Chan ACK; Kobylarz MJ; Murphy MEP; Eltis LD
J Biol Chem; 2017 Nov; 292(44):18290-18302. PubMed ID: 28935670
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the bi-functionality of human oxaloacetate decarboxylase FAHD1.
Weiss AKH; Naschberger A; Loeffler JR; Gstach H; Bowler MW; Holzknecht M; Cappuccio E; Pittl A; Etemad S; Dunzendorfer-Matt T; Scheffzek K; Liedl KR; Jansen-Dürr P
Biochem J; 2018 Nov; 475(22):3561-3576. PubMed ID: 30348641
[TBL] [Abstract][Full Text] [Related]
18. Molecular Aspects of the FAH Mutations Involved in HT1 Disease.
Morrow G; Angileri F; Tanguay RM
Adv Exp Med Biol; 2017; 959():25-48. PubMed ID: 28755182
[TBL] [Abstract][Full Text] [Related]
19. Compound mutations (R237X and L375P) in the fumarylacetoacetate hydrolase gene causing tyrosinemia type I in a Chinese patient.
Cao YY; Zhang YL; DU J; Qu YJ; Zhong XM; Bai JL; Song F
Chin Med J (Engl); 2012 Jun; 125(12):2132-6. PubMed ID: 22884142
[TBL] [Abstract][Full Text] [Related]
20. Identification of FAH domain-containing protein 1 (FAHD1) as oxaloacetate decarboxylase.
Pircher H; von Grafenstein S; Diener T; Metzger C; Albertini E; Taferner A; Unterluggauer H; Kramer C; Liedl KR; Jansen-Dürr P
J Biol Chem; 2015 Mar; 290(11):6755-62. PubMed ID: 25575590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
